Amritadi kwath in asthma

Phase 1

• Conditions: Health Condition 1: J454- Moderate persistent asthma

• Registration Number: CTRI/2020/04/024654
• Lead Sponsor: Harsha Radhakrishnan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-04-15
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Other (Terminated)
• Sex: Not specified
• Target Recruitment: 27

Inclusion Criteria

a.Patients presenting with signs and symptoms of Tamaka Shwasa for equal to and more than one year as described in Ayurvedic texts.

b.Patients presenting with 3 or more of the following symptoms-

1.Pinasa2.Ghurghurak3.Aasya Udhvansa

4. Kantodhvansa5.Vak kricchrata6.Lalat Sweda

7.Parshvagraha8.Ushnabhiprayata9.Aasya Shushkata

10.Vepathu11.Aruchi12.Annadvesh

c.Mild intermittent, mild persistent, moderate persistent asthma according to global initiative for asthma (GINA) guidelines.

d.Blood Oxygen saturation(spO2) >90%.

e.PEFR >100 litre/min.

f.Age 20-60 years.

Exclusion Criteria

a.Severe persistent asthma according to global initiative for asthma (GINA) guidelines

b.H/O Tuberculosis, COPD, Emphysema, Other complicated respiratory diseases.

c.Known case of Hypertension and cardiac involvement.

d.PEFR < 100 litre/min.

e.Blood Oxygen saturation (spO2 < 90%)

f.H/O Endocrine disorders like Diabetes mellitus.

g.Patients with frequent H/O hospitalization due to Status Asthmaticus.

Study & Design

• Study Type: Interventional
• Study Design: Not specified